Publication | Closed Access
Vasoactive Intestinal Polypeptide and Phentolamine Mesylate Administered by Autoinjector in the Treatment of Patients With Erectile Dysfunction Resistant to Other Intracavernosal Agents
23
Citations
1
References
1998
Year
Molecular PharmacologyUrologyVoiding DysfunctionErectile DysfunctionVasoactive Intestinal PolypeptideErectile Dysfunction ResistantMedicineNorthern Ireland© 1998Sexual DysfunctionFemale UrologyNeuropharmacologyUrologyurological SurveyPharmacotherapyUrogynecologyPharmacologyPhentolamine Mesylate Administered
No AccessJournal of UrologyUrological Survey: Abstracts: Sexual Function and Dysfunction1 Nov 1998Vasoactive Intestinal Polypeptide and Phentolamine Mesylate Administered by Autoinjector in the Treatment of Patients With Erectile Dysfunction Resistant to Other Intracavernosal Agents W.W. Dinsmore, and D.K. Alderdice W.W. DinsmoreW.W. Dinsmore More articles by this author , and D.K. AlderdiceD.K. Alderdice More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)62476-5AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Vasoactive Intestinal Polypeptide and Phentolamine Mesylate Administered by Autoinjector in the Treatment of Patients With Erectile Dysfunction Resistant to Other Intracavernosal Agents." The Journal of Urology, 160(5), p. 1946 Department of Genito-Urinary Medicine, Royal Victoria Hospital, Belfast, Northern Ireland© 1998 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 160Issue 5November 1998Page: 1946 Advertisement Copyright & Permissions© 1998 by American Urological Association, Inc.MetricsAuthor Information W.W. Dinsmore More articles by this author D.K. Alderdice More articles by this author Expand All Advertisement Loading ...
| Year | Citations | |
|---|---|---|
Page 1
Page 1